News
What I discovered over the course of my career is that we rarely think of business models themselves as vehicles for ...
3d
On January 16, 2025, Avacta reported encouraging results from its Phase I trial of AVA6000. In patients with salivary gland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback